📊 Evidence-Based Reference
n-terface
Winfield Laboratories
Summary: The n-terface is a nonadherent wound dressing used primarily in wound care management. Key evidence highlights its effectiveness in reducing postoperative pain and promoting rapid healing.
FDA Clearance Information
Pathway
510K
Number
K973538 ↗
Decision Date
December 16, 1997
Product Code
MGP
Device Class
—
Evidence
0 studies
The n-terface was cleared through the FDA 510k pathway on December 16, 1997, by Winfield Laboratories. It is classified under product code MGP with no specific regulatory class.
What It Is
The n-terface is a nonadherent wound dressing designed to facilitate wound healing by providing a protective barrier while allowing for moisture retention. It is intended for use in various wound care scenarios, including post-surgical applications.
Clinical Applications
Commonly used in wound care management, the n-terface is applied in scenarios such as post-laser skin resurfacing and treatment of infected soft tissue wounds. It is valued for its ability to reduce pain and enhance healing.
Evidence Summary
The available literature includes three studies ranging from 1990 to 2017, encompassing various study designs such as RCTs and case series. These studies explore the efficacy and safety of the n-terface in different clinical settings.
Reported Outcomes
Published studies report that the n-terface dressing is associated with low postoperative pain, rapid healing, and excellent wound bed visualization. It has been effective in both open and closed wound management, particularly after laser skin resurfacing.
Safety Profile
Reported complications include minimal adverse events, with studies noting the absence of crust formation and painless dressing removal. The nonadherent nature of the dressing contributes to its favorable safety profile.
Evidence Limitations
The evidence is limited by the small number of studies and the lack of large-scale randomized controlled trials. Further research is needed to explore long-term outcomes and compare efficacy with other wound dressings.
Frequently Asked Questions
What are the clinical indications for n-terface?
The n-terface is indicated for use in wound care management, particularly in post-surgical and laser skin resurfacing scenarios.
What outcomes have been reported in clinical studies?
Studies have reported low postoperative pain, rapid healing, and excellent wound bed visualization with the use of n-terface.
What complications have been reported?
Reported complications include minimal adverse events, with studies highlighting the absence of crust formation and painless dressing removal.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.